Substantial reduction in all-cause mortality and morbidity with candesartan in patients with chronic heart failure and systolic left ventricular dysfunction: results of the CHARM low EF trials Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Young, J
  • Swedberg, K
  • Dunlap, ME
  • Granger, CB
  • McMurray, JJV
  • Probstfield, JL
  • Yusuf, Salim
  • Pfeffer, M

publication date

  • August 1, 2004